Respiratory diseases are a challenging problem to treat. Inhalable medicines are a promising solution that depends on the ...

A multimodal, digital community-based intervention was feasible and decreased illness-related distress in treating patients ...

Among patients with pulmonary arterial hypertension treated with 72-week seralutinib, those deemed responders had more improved measures, according to a poster presented at the Pulmonary Vascular ...